Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition.

Abstract

BACKGROUND:

The discovery of new anti-melanoma drugs with low side effect is urgently required in the clinic. Recent studies showed that morusin, a flavonoid compound isolated from the root bark of Morus Alba, has the potential to treat multiple types of cancers, including breast cancer, gastric cancer, and prostate cancer. However, the anti-cancer effect of morusin on melanoma cells has not been investigated.

METHODS:

We analyzed the effects of morusin on the proliferation, cell cycle, apoptosis, cell migration and invasion ability of melanoma cells A375 and MV3, and further explored the effects of morusin on tumor formation of melanoma cell. Finally, the effects of morusin on the proliferation, cycle, apoptosis, migration and invasion of A375 cells after knockdown of p53 were detected.

RESULTS:

Morusin effectively inhibits the proliferation of melanoma cells and induces cell cycle arrest in the G2/M phase. Consistently, CyclinB1 and CDK1 that involved in the G2/M phase transition were down-regulated upon morusin treatment, which may be caused by the up-regulation of p53 and p21. In addition, morusin induces cell apoptosis and inhibits migration of melanoma cells, which correlated with the changes in the expression of the associated molecules including PARP, Caspase3, E-Cadherin and Vimentin. Moreover, morusin inhibits tumor growth in vivo with little side effect on the tumor-burden mice. Finally, p53 knockdown partially reversed morusin-mediated cell proliferation inhibition, cell cycle arrest, apoptosis, and metastasis.

CONCLUSION:

Collectively, our study expanded the spectrum of the anti-cancer activity of morusin and guaranteed the clinical use of the drug for melanoma treatment.

• Authors: Wei Liu, Yacong Ji, Feng Wang, Chongyang Li, Shaomin Shi, Ruochen Liu, Qian Li, Leiyang Guo, Yaling Liu, Hongjuan Cui
• Journal: BMC cancer (BMC Cancer) Vol. 23 Issue 1 Pg. 602 (Jun 29 2023) ISSN: 1471-2407 [Electronic] England
• PMID: 37386395 (Publication Type: Journal Article)
• Copyright: © 2023. The Author(s).

Chemical References

• morusin
• Tumor Suppressor Protein p53
• Flavonoids

Topics

• Male
• Animals
• Mice
• Tumor Suppressor Protein p53 (genetics)
• Melanoma (drug therapy)
• Flavonoids (pharmacology, therapeutic use)
• Apoptosis